Researchers from Turkey’s Ege and Istinye Universities reported the coexistence of sarcoidosis and gouty arthritis in a 45-year-old man. Their study,  “Coexistence of Sarcoidosis and Gouty Arthritis.” appeared in the Spanish journal Reumatología Clínica. Sarcoidosis is a rare inflammatory disease characterized by the formation of granulomas in organs of…

Therapies used to treat pulmonary hypertension (PH), such as Revatio (sildenafil), provide only temporary benefit for patients with sarcoidosis-associated PH, according to a case report published in the journal Advances in Respiratory Medicine. The report demonstrates that such therapies fail to prevent disease progression and improve patients’ outcomes, highlighting the…

Treatment with medications for pulmonary arterial hypertension (PAH) do not significantly help people with sarcoidosis-associated pulmonary hypertension (PH), researchers from France’s University of Paris-Sud reported. Their study, “Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension,” — published in the European Respiratory Journal — showed that while PAH-drugs improved some disease…

A recent report in the journal Internal Medicine, published by the Japanese Society of Internal Medicine, described the unusual case of a 78-year-old woman who had a rare combination of pancreatic mass and nodules in the airways and lungs — all consistent with a diagnosis of sarcoidosis. Sarcoidosis is characterized…

The U.S. Food and Drug Administration (FDA) recently awarded six research grants for natural history studies in rare diseases. One of the grants was awarded to Alicia Gerke, assistant professor of pulmonary, critical care, and occupational medicine at the University of Iowa. Gerke will receive approximately $300,000 over two…

Tumor necrosis factor (TNF) antagonists are effective therapies in a significant proportion of patients with severe and refractory sarcoidosis, a new study shows. However, they also are associated with adverse events such as infections and allergic reactions. The study titled, “Efficacy and safety of tumor necrosis factor…

A U.S. nationwide study found the number of cardiac sarcoidosis (CS) cases doubled from 2005 to 2011, concluding that the disease may not be as rare as researchers thought. CS is a life-threatening disease characterized by inflammation and accumulation of white blood cells in the heart. It is considered…

A research team at the Mayo Clinic in Rochester, Minnesota, evaluated the clinical records of cases of hepatic sarcoidosis over a 37-year period to describe the characteristics of the condition. The work results from the fact that the clinical characteristics and outcome of hepatic sarcoidosis are still not well-defined, and most of…

Patients with sarcoidosis have lower coronary flow velocity reserve (CFVR), a measure of disturbances in blood flow in heart muscles, compared to healthy volunteers, researchers found. The study, “Coronary flow reserve is reduced in sarcoidosis,” was published in the journal Atherosclerosis. CFVR is the maximum…

The incidence of sarcoidosis may be associated with breast cancer, according to a short report published in the European Journal of Internal Medicine. This finding highlights the importance of a suitable breast cancer patient’s follow-up to ensure early diagnosis and treatment of sarcoidosis. Sarcoidosis is believed to be caused…